RE:RE:RE:Extra lump of coal in our stocking this year I believe they need to make formulation changes for their current VTM to be a better fit for applications outside of COVID testing in Ontario, my understanding is that they are making those changes and then would need to get approval. I don't think this is an expensive or long term project, but that it will take some time. Will be looking for clarity on this in the webinar as well as status on all the upgrades they have been doing both physical and software related.
I'm a very long term holder on this and was also disappointed in Q4, however, having been in sales for a good portion of my career I also very much understand how difficult order timing can be. With diagnostics being a very regulated industry delays are to be expected and I'm still certain that the "many" additional QAPs contracts they have been talking about for the last six months are still in the pipeline. Long term the diagnostics industry will be a very good place to be in my opinion which is why I'm still very bullish, and financially they are in the best position I can recall.
Kinlytic is a huge wildcard and one of the reasons I got into this stock many many moons ago, I do think that if any management team is going to get something over the finish line here it will be this one, but I'm not holding my breath anymore. If it comes in 2023 it will be icing on what im hoping to be a very sweet cake.